HK1169106A1 - 製備氮雜二環化合物的方法 - Google Patents

製備氮雜二環化合物的方法

Info

Publication number
HK1169106A1
HK1169106A1 HK12109705.3A HK12109705A HK1169106A1 HK 1169106 A1 HK1169106 A1 HK 1169106A1 HK 12109705 A HK12109705 A HK 12109705A HK 1169106 A1 HK1169106 A1 HK 1169106A1
Authority
HK
Hong Kong
Prior art keywords
azabicyclic compounds
preparing
preparing azabicyclic
compounds
azabicyclic
Prior art date
Application number
HK12109705.3A
Other languages
English (en)
Inventor
．安部海卡
．比爾
．凡寧
．胡格赫斯
．利特勒
Original Assignee
沃泰克斯藥物股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 沃泰克斯藥物股份有限公司 filed Critical 沃泰克斯藥物股份有限公司
Publication of HK1169106A1 publication Critical patent/HK1169106A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B61/00—Other general methods
    • C07B61/02—Generation of organic free radicals; Organic free radicals per se
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C211/34—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of a saturated carbon skeleton
    • C07C211/35—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of a saturated carbon skeleton containing only non-condensed rings
HK12109705.3A 2009-09-17 2012-10-03 製備氮雜二環化合物的方法 HK1169106A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24347709P 2009-09-17 2009-09-17
PCT/US2010/049306 WO2011035139A1 (en) 2009-09-17 2010-09-17 Process for preparing azabicyclic compounds

Publications (1)

Publication Number Publication Date
HK1169106A1 true HK1169106A1 (zh) 2013-01-18

Family

ID=43242763

Family Applications (1)

Application Number Title Priority Date Filing Date
HK12109705.3A HK1169106A1 (zh) 2009-09-17 2012-10-03 製備氮雜二環化合物的方法

Country Status (16)

Country Link
US (2) US8404865B2 (zh)
EP (1) EP2477991B1 (zh)
JP (1) JP5793496B2 (zh)
KR (1) KR20120083416A (zh)
CN (1) CN102498112B (zh)
AU (1) AU2010295461B2 (zh)
BR (1) BR112012006031A2 (zh)
CA (1) CA2772792A1 (zh)
ES (1) ES2540810T3 (zh)
HK (1) HK1169106A1 (zh)
IL (1) IL218641A0 (zh)
MX (1) MX2012003343A (zh)
NZ (1) NZ598277A (zh)
RU (1) RU2543622C2 (zh)
WO (1) WO2011035139A1 (zh)
ZA (1) ZA201201252B (zh)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100074949A1 (en) 2008-08-13 2010-03-25 William Rowe Pharmaceutical composition and administration thereof
KR20060088537A (ko) 2003-09-06 2006-08-04 버텍스 파마슈티칼스 인코포레이티드 Ａｔｐ-결합 카세트 수송체의 조절자
US7407976B2 (en) * 2003-11-14 2008-08-05 Vertex Pharmaceuticals Incorporated Thiazoles and oxazoles useful as modulators of ATP-Binding Cassette transporters
US7977322B2 (en) 2004-08-20 2011-07-12 Vertex Pharmaceuticals Incorporated Modulators of ATP-binding cassette transporters
EP2532650A3 (en) 2004-06-24 2013-11-06 Vertex Pharmaceuticals Incorporated Modulators of ATP-binding cassette transporters
MX2008002019A (es) 2005-08-11 2008-04-16 Vertex Pharma Moduladores del regulador de conductancia transmembrana de fibrosis quistica.
EP2404919B1 (en) 2005-11-08 2013-08-21 Vertex Pharmaceuticals Incorporated Heterocyclic compound useful as a modulator of ATP-binding cassette transporters.
PL3219705T3 (pl) 2005-12-28 2020-08-10 Vertex Pharmaceuticals Incorporated Kompozycje farmaceutyczne amorficznych postaci n-[2,4-bis(1,1-dimetyloetylo)-5-hydroksyfenylo]-1,4-dihydro-4-oksochinolino-3-karboksyamidu
AU2006336504C9 (en) 2005-12-28 2015-05-14 Vertex Pharmaceuticals Incorporated 1-(benzo [D] [1,3] dioxol-5-yl) -N- (phenyl) cyclopropane- carboxamide derivatives and related compounds as modulators of ATP-Binding Cassette transporters for the treatment of Cystic Fibrosis
US10022352B2 (en) 2006-04-07 2018-07-17 Vertex Pharmaceuticals Incorporated Modulators of ATP-binding cassette transporters
MX2008012945A (es) 2006-04-07 2009-01-15 Vertex Pharma Moduladores de transportadores de cartucho de union a adenosina-trifosfato celular (atp).
US7645789B2 (en) 2006-04-07 2010-01-12 Vertex Pharmaceuticals Incorporated Indole derivatives as CFTR modulators
US8563573B2 (en) * 2007-11-02 2013-10-22 Vertex Pharmaceuticals Incorporated Azaindole derivatives as CFTR modulators
CN101687842B (zh) 2007-05-09 2013-03-06 沃泰克斯药物股份有限公司 Cftr调节剂
EP2187884B1 (en) 2007-08-24 2016-03-30 Vertex Pharmaceuticals Incorporated Isothiazolopyridinones useful for the treatment of (inter alia) cystic fibrosis
CA2705562C (en) 2007-11-16 2016-05-17 Vertex Pharmaceuticals Incorporated Isoquinoline modulators of atp-binding cassette transporters
US20100036130A1 (en) * 2007-12-07 2010-02-11 Vertex Pharmaceuticals Incorporated Processes for producing cycloalkylcarboxamido-pyridine benzoic acids
CA2708146A1 (en) * 2007-12-07 2009-06-18 Vertex Pharmaceuticals Incorporated Formulations of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid
LT2639224T (lt) 2007-12-07 2016-10-25 Vertex Pharmaceuticals Incorporated Cikloalkilkarboksiamidopiridinbenzenkarboksirūgščių gavimo būdas
MX367154B (es) 2007-12-07 2019-08-07 Vertex Pharma Formas solidas de acido 3-(6-(1-(2,2-difluorobenzo[d] [1,3]dioxol-5-il)ciclopropancarboxamido)-3-metilpiridin-2-il)benz oico.
CA2931134C (en) 2008-02-28 2019-07-30 Vertex Pharmaceuticals Incorporated Heteroaryl derivatives as cftr modulators
CN103951614A (zh) 2008-03-31 2014-07-30 沃泰克斯药物股份有限公司 作为cftr调节剂的吡啶基衍生物
RU2011117177A (ru) * 2008-09-29 2012-11-10 Вертекс Фармасьютикалз Инкорпорейтед (Us) ДОЗИРОВАННЫЕ ЛЕКАРСТВЕННЫЕ ФОРМЫ 3-(6-(1-(2,2-ДИФТОРБЕНЗО[d][1,3]ДИОКСОЛ-5-ИЛ)ЦИКЛОПРОПАНКАРБОКСАМИДО)-3-МЕТИЛПИРИДИН-2-ИЛ)БЕНЗОЙНОЙ КИСЛОТЫ
UA104601C2 (uk) * 2008-10-23 2014-02-25 Вертекс Фармасьютікалз, Інкорпорейтед Модулятори регулятора трансмембранної провідності при муковісцидозі
US8476442B2 (en) 2009-03-20 2013-07-02 Vertex Pharmaceutical Incorporated Process for making modulators of cystic fibrosis transmembrane conductance regulator
MX2012003343A (es) * 2009-09-17 2012-08-17 Vertex Pharma Proceso para preparar compuestos azabiciclicos.
US8802868B2 (en) 2010-03-25 2014-08-12 Vertex Pharmaceuticals Incorporated Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxo1-5-yl)-N-(1-(2,3-dihydroxypropyl-6-fluoro-2-(1-hydroxy-2-methylpropan2-yl)-1H-Indol-5-yl)-Cyclopropanecarboxamide
JP2013523833A (ja) 2010-04-07 2013-06-17 バーテックス ファーマシューティカルズ インコーポレイテッド ３−（６−（１−（２，２−ジフルオロベンゾ［ｄ］［１，３］ジオキソール−５−イル）シクロプロパンカルボキサミド）−３−メチルピリジン−２−イル）安息香酸の医薬組成物およびその投与
SI2555754T1 (sl) 2010-04-07 2016-07-29 Vertex Pharmaceuticals Incorporated Trdne farmacevtske oblike 3-(6-(1-(2,2-difluoro-benzo(d)(1,3)dioksol-5- il)ciklopropankarboksamido)-3-metilpiridin-2-il)benzojske kisline
NZ603721A (en) 2010-04-22 2014-11-28 Vertex Pharma Process of producing cycloalkylcarboxamido-indole compounds
EP2560650A1 (en) 2010-04-22 2013-02-27 Vertex Pharmaceuticals Incorporated Pharmaceutical compositions and administrations thereof
EP2560649A1 (en) 2010-04-22 2013-02-27 Vertex Pharmaceuticals Incorporated Pharmaceutical compositions and administrations thereof
US8563593B2 (en) 2010-06-08 2013-10-22 Vertex Pharmaceuticals Incorporated Formulations of (R)-1-(2,2-difluorobenzo[D] [1,3] dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide
EP2776427B1 (en) 2011-11-08 2017-02-01 Vertex Pharmaceuticals Incorporated Modulators of atp-binding cassette transporters
RU2692779C2 (ru) 2012-02-27 2019-06-27 Вертекс Фармасьютикалз Инкорпорейтед Фармацевтическая композиция и ее введения
CN102633804B (zh) * 2012-04-19 2014-09-24 中南大学 一种制备7-氮杂双环[2.2.1]庚烷的方法
US8674108B2 (en) 2012-04-20 2014-03-18 Vertex Pharmaceuticals Incorporated Solid forms of N-[2,4-bis(1,1-dimethylethy)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
CA2878057A1 (en) 2012-07-16 2014-01-23 Rossitza Gueorguieva Alargova Pharmaceutical compositions of (r)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-n-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1h-indol-5-yl) cyclopropanecarboxamide and administration thereof
PL3068392T3 (pl) 2013-11-12 2021-07-19 Vertex Pharmaceuticals Incorporated Proces wytwarzania kompozycji farmaceutycznych do leczenia chorób, w których pośredniczy cftr
SG10201913575VA (en) 2014-04-15 2020-02-27 Vertex Pharma Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseases
CN107250113B (zh) 2014-10-07 2019-03-29 弗特克斯药品有限公司 囊性纤维化跨膜传导调节蛋白的调节剂的共晶
MX2017006443A (es) 2014-11-18 2017-09-11 Vertex Pharma Proceso para efectuar la prueba de alto rendimiento de la cromatografia liquida de alta resolucion.

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6060473A (en) 1993-04-01 2000-05-09 Ucb S.A. - Dtb 7-azabicyclo[2.2.1]-heptane and -heptene derivatives as cholinergic receptor ligands
JPH06312989A (ja) * 1993-04-30 1994-11-08 Nippon Chemiphar Co Ltd （１ｒｓ，２ｒｓ，４ｓｒ）−２−（６−クロロ−３−ピリジル）−７−アザビシクロ［２．２．１］ヘプタンの製造方法
US6117889A (en) 1994-04-01 2000-09-12 University Of Virginia 7-Azabicyclo-[2.2.1]-heptane and -heptene derivatives as analgesics and anti-inflammatory agents
TW200407127A (en) * 2002-08-21 2004-05-16 Astrazeneca Ab Chemical compounds
US20070167428A1 (en) * 2004-02-20 2007-07-19 Astrazeneca Ab Thienopyrroles as antagonists of gnrh
EP2532650A3 (en) * 2004-06-24 2013-11-06 Vertex Pharmaceuticals Incorporated Modulators of ATP-binding cassette transporters
CA2594785A1 (en) * 2005-01-21 2006-07-27 Pfizer Limited Crystalline forms cis-5-fluoro-n-[4-(2-hydroxy-4-methylbenzamido) cyclohexyl]-2-(tetrahydrothiopyran-a-yloxy) nicotinamide
JP5126856B2 (ja) * 2007-03-28 2013-01-23 国立大学法人 長崎大学 含窒素レドックス触媒
UA104601C2 (uk) * 2008-10-23 2014-02-25 Вертекс Фармасьютікалз, Інкорпорейтед Модулятори регулятора трансмембранної провідності при муковісцидозі
PL2358680T3 (pl) * 2008-10-23 2013-08-30 Vertex Pharma Stałe postacie N-(4-(7-azabicyklo[2.2.1]heptan-7-ylo)-2-(trifluorometylo)fenylo)-4-okso-5-(trifluorometylo)-1,4-dihydrochinolino-3-karboksyamidu
MX2012003343A (es) * 2009-09-17 2012-08-17 Vertex Pharma Proceso para preparar compuestos azabiciclicos.
US8389727B2 (en) * 2009-10-23 2013-03-05 Vertex Pharmaceuticals Incorporated Solid forms of N-(4-(7-Azabicyclo[2.2.1]Heptan-7-yl)-2-Trifluoromethyl)Phenyl)-4-Oxo-5-(Trifluoromethyl)-1,4-Dihydroquinoline-3-Carboxamide
CN102648182A (zh) * 2009-10-23 2012-08-22 沃泰克斯药物股份有限公司 用于制备囊性纤维化跨膜传导调节因子的调节剂的方法
AR081920A1 (es) * 2010-05-20 2012-10-31 Vertex Pharma Procesos de produccion de moduladores del regulador de conductancia transmembrana de fibrosis quistica

Also Published As

Publication number Publication date
ZA201201252B (en) 2013-05-29
RU2543622C2 (ru) 2015-03-10
JP2013505259A (ja) 2013-02-14
EP2477991B1 (en) 2015-04-15
AU2010295461A1 (en) 2012-03-08
US20110065928A1 (en) 2011-03-17
US8404865B2 (en) 2013-03-26
US8461352B2 (en) 2013-06-11
US20120259129A1 (en) 2012-10-11
AU2010295461B2 (en) 2016-03-03
BR112012006031A2 (pt) 2019-09-24
MX2012003343A (es) 2012-08-17
IL218641A0 (en) 2012-05-31
CN102498112B (zh) 2015-05-20
ES2540810T3 (es) 2015-07-13
EP2477991A1 (en) 2012-07-25
NZ598277A (en) 2014-03-28
CA2772792A1 (en) 2011-03-24
RU2012115111A (ru) 2013-10-27
JP5793496B2 (ja) 2015-10-14
CN102498112A (zh) 2012-06-13
WO2011035139A1 (en) 2011-03-24
KR20120083416A (ko) 2012-07-25

Similar Documents

Publication Publication Date Title
HK1169106A1 (zh) 製備氮雜二環化合物的方法
HRP20160868T1 (hr) Postupak za pripremanje hidromagnezita
IL214600A0 (en) Process for preparing substituted 2-nitrobiphenyls
IL220357A0 (en) Process for preparing substituted 1-o-acyl-2-deoxy-2-fluoro-4-thio-beta-d-arabinofuranoses
EP2464650A4 (en) PROCESSES FOR PREPARING PEMETREXED
ZA201102424B (en) Process for preparing 2-alkyl-3-aroyl-5-nitro-benzofurans
EP2534127A4 (en) PROCESS FOR PREPARING (R) 2-ACETAMIDO-N-BENZYL-3-METHOXY-PROPIONAMIDE
PL2390243T3 (pl) Sposób wytwarzania bisfenolu
ZA201207386B (en) Process for preparing benzoxaboroles
PT2473477E (pt) Método de produção de mononitrotolueno
IL218140A0 (en) Process for preparing 1-phenylpyrazoles
EP2404985A4 (en) PROCESS FOR PRODUCING LIPID
IL208514A0 (en) Process for preparing substituted biphenylanilides
PL2477964T3 (pl) Proces wytwarzania pochodnych alfa-karboksyamidu
IL207222A0 (en) Process for preparing hebivolol
SI2516359T1 (sl) Postopek za pripravo etilbenzena
IL223145A0 (en) Process for preparing dithiine-tetracarboxy-diimides
ZA201204825B (en) Process for preparing biocides
EP2585436A4 (en) PROCESS FOR THE PREPARATION OF 4-HYDROXYPYRIDINES
EP2487150A4 (en) PROCESS FOR PRODUCING 2 ALKYLCYCLOALCANONE
IL217802A0 (en) Process for preparing cinacalcet
IL217139A0 (en) Process for the preparation of arylpyridinyl compounds
EP2408785A4 (en) PROCESS FOR THE PREPARATION OF ORGANOSILANES
PT2414283E (pt) Processo para a produção de cloro
IL215023A0 (en) Novel process for preparing enaminocarbonyl compounds

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20190915